Document is current
Any future updates will be listed below
-
Authors
Paramo Fernandez, Raquel https://orcid.org/0009-0005-3394-7692
Fargas Baella, Gemma https://orcid.org/0009-0009-8451-9013
Slavova-Boneva, Vanya https://orcid.org/0009-0004-5415-0300
Battisti, Nicolò Matteo Luca https://orcid.org/0000-0002-1063-1717
- License Information
-
More Information
Article History
Accepted: 30 January 2025
First Online: 20 February 2025
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Nicolò Matteo Luca Battisti: advisory board: Pfizer, Abbott, Sanofi, Astellas, and Merck; travel grants: Exact Sciences, Pfizer, Lilly, and Novartis; speaker fees: Pfizer, AbbVie, Roche, Sanofi, Novartis, Servier, Gilead, AstraZeneca, Lilly, and Exact Sciences. Raquel Paramo Fernandez, Gemma Fargas Baella, and Vanya Slavova-Boneva declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
